For the Quarter Ending June 2026
Neomycin Sulphate Prices in North America
- In the United States, the Neomycin Sulphate Price Index rose in Q2 2026, driven by rising production costs and robust consumer demand.
- Neomycin Sulphate production costs increased in Q2 2026, as the Producer Price Index rose 5.5% year-over-year in June 2026.
- Demand for Neomycin Sulphate was supported by a 6.9% year-over-year rise in retail sales in May 2026, boosting consumer-facing products.
- Neomycin Sulphate Price Index faced upward pressure from a 3.5% year-over-year CPI increase in June 2026, raising operational expenses.
- The US pharmaceutical market expanded in 2026, with an optimistic life sciences outlook and new product adoption during Q2 2026.
- Industrial electricity prices increased in April 2026, contributing to higher production costs for Neomycin Sulphate manufacturers.
- Wholesale natural gas prices remained near annual lows in April 2026, with Henry Hub futures edging lower in June 2026.
- Overall industrial production grew sluggishly by 0.7% year-over-year in June 2026, impacting broader manufacturing and some end-use sectors.
Why did the price of Neomycin Sulphate change in June 2026 in North America?
- Producer Price Index rose 5.5% year-over-year in June 2026, increasing raw material costs.
- Strong retail sales growth of 6.9% year-over-year in May 2026 boosted consumer demand.
- Industrial electricity prices increased in April 2026, contributing to higher manufacturing expenses.
Neomycin Sulphate Prices in APAC
- In China, the Neomycin Sulphate Price Index rose quarter-over-quarter in Q2 2026, driven by increasing production costs.
- Neomycin Sulphate prices were assessed at USD 12,100/MT FOB China.
- Neomycin Sulphate production costs trended upward in Q2 2026, influenced by a 4.1% PPI increase in June 2026.
- Domestic demand for pharmaceutical applications of Neomycin Sulphate remained steady in Q2 2026.
- Petrochemical production costs trended upward in Q2 2026, following higher crude oil prices.
- Weakened household consumption and private demand in Q2 2026, with 1.0% retail sales growth in June, moderated demand.
- China's industrial output grew by 5.3% in June 2026, with manufacturing factory activity recovering.
- Corn feedstock prices marginally decreased in April and May 2026, then increased in June.
- A 5.0% unemployment rate in June 2026 indicated a stable labor market, supporting demand for healthcare products.
Why did the price of Neomycin Sulphate change in June 2026 in APAC?
- Rising production costs, evidenced by a 4.1% PPI increase in June 2026, pressured prices upward.
- Upward-trending petrochemical costs in Q2 2026, linked to higher crude oil prices, increased manufacturing expenses.
- Weakened household consumption and private demand in Q2 2026, with 1.0% retail sales growth, moderated demand.
Neomycin Sulphate Prices in Europe
- In Germany, the Neomycin Sulphate Price Index rose in Q2 2026, driven by increased production costs.
- Neomycin Sulphate production costs increased in Q2 2026 due to a 2.2% rise in PPI in May.
- Neomycin Sulphate demand outlook was mixed in Q2 2026, with strengthening pharmaceutical needs.
- Neomycin Sulphate price trends in Q2 2026 reflected persistent cost inflation and robust export volumes.
- Pharmaceutical market growth continued in Q2 2026, while the chemical industry business climate weakened.
- Demand for Neomycin Sulphate was driven by an aging population and increasing healthcare needs.
- Elevated industrial electricity and natural gas prices impacted Neomycin Sulphate production costs.
- Robust pharmaceutical export volumes in Q2 2026 contrasted with intensified supply chain disruptions.
- Policy changes included government cost-containment measures and electricity price relief in Q2 2026.
Why did the price of Neomycin Sulphate change in June 2026 in Europe?
- Producer prices rose 2.2% in May 2026, increasing Neomycin Sulphate manufacturing costs.
- Consumer Price Index increased 2.3% in June 2026, reflecting higher raw material costs.
- Robust pharmaceutical export volumes in Q2 2026 supported demand despite contracting industrial confidence.
For the Quarter Ending March 2026
Neomycin Sulphate Prices in North America
- In United States, the Neomycin Sulphate Price Index rose quarter-over-quarter in Q1 2026, driven by surging sulfuric acid production costs.
- The Neomycin Sulphate Production Cost Trend increased sharply in March 2026 as producer prices rose 4.0% year-over-year.
- The Neomycin Sulphate Demand Outlook strengthened during early Q1 2026, supported by expanding domestic manufacturing index activity.
- Retail sales grew 4.0% in March 2026, sustaining Neomycin Sulphate consumption in over-the-counter human pharmaceutical products.
- A 4.3% unemployment rate and 91.8 consumer confidence in March 2026 maintained steady veterinary medicine end-market purchases.
- Industrial production grew 0.7% in March 2026, ensuring stable bulk processing for the domestic Neomycin Sulphate market.
- While corn-derived feedstock costs stabilized in early Q1 2026, headline consumer inflation reached 3.3% in March 2026.
- The Neomycin Sulphate Price Forecast remained elevated through March 2026 due to severe Middle East logistics disruptions.
Why did the price of Neomycin Sulphate change in March 2026 in North America?
- Sulfuric acid production costs surged in March 2026 amid acute global supply chain and trade disruptions.
- Pharmaceutical sector procurement activity expanded in early Q1 2026, reacting directly to mounting international logistics disruptions.
- Producer prices rose 4.0% in March 2026, reflecting elevated input costs for active pharmaceutical ingredient manufacturing.
Neomycin Sulphate Prices in APAC
- In China, the Neomycin Sulphate Price Index rose quarter-over-quarter in Q1 2026, driven by surging fermentation feedstock costs.
- Producer Price Index increased 0.5% in March 2026, elevating the Neomycin Sulphate Production Cost Trend.
- Consumer Price Index grew 1.0% in March 2026, supporting the Neomycin Sulphate Demand Outlook steadily.
- Industrial production expanded 5.7% and the Manufacturing Index expanded in March 2026, boosting formulation activity.
- Retail sales grew 1.7% and unemployment reached 5.4% in March 2026, dampening discretionary medicine purchases.
- Consumer confidence hit 91.6 in February 2026, while hog cash prices plummeted in March 2026.
- Soybean meal and corn spot prices surged in March 2026, lifting agricultural fermentation feedstock expenses.
- Domestic supply availability tightened during Q1 2026 as producers underwent stringent environmental and compliance upgrades.
- Ocean freight rates surged in Q1 2026, elevating costs and shaping Neomycin Sulphate Price Forecast.
Why did the price of Neomycin Sulphate change in March 2026 in APAC?
- Soybean meal and corn fermentation feedstock costs surged significantly across the region in March 2026.
- Domestic supply availability tightened sharply during Q1 2026 as producers completed stringent environmental compliance upgrades.
- Veterinary medicine and functional feed additive demand strengthened robustly throughout the market in January 2026.
Neomycin Sulphate Prices in Europe
- In Germany, the Neomycin Sulphate Price Index rose quarter-over-quarter in Q1 2026, driven by surging input cost inflation.
- The Consumer Price Index increased by 2.7% in March 2026, elevating the Neomycin Sulphate production cost trend.
- The Producer Price Index declined by 0.2% in March 2026, indicating slightly easing upstream chemical solvent costs.
- Industrial production remained stagnant at 0.0% in February 2026, capping bulk veterinary formulation volume for Neomycin Sulphate.
- Retail sales grew by 0.7% in February 2026, supporting steady consumer demand for Neomycin Sulphate topical creams.
- A stable 4.2% unemployment rate in February 2026 sustained household spending on companion animal treatments requiring Neomycin Sulphate.
- Consumer confidence dropped to -24.7 in March 2026, negatively impacting the premium Neomycin Sulphate demand outlook.
- Veterinary pharmaceutical demand for Neomycin Sulphate strengthened in Q1 2026, driving a positive Neomycin Sulphate price forecast.
Why did the price of Neomycin Sulphate change in March 2026 in Europe?
- European natural gas prices spiked in March 2026, significantly increasing energy-intensive Neomycin Sulphate fermentation costs.
- Asia-bound logistics disruptions lengthened supplier delivery times in Q1 2026, tightening regional Neomycin Sulphate availability.
- Input cost inflation for German manufacturers surged in March 2026, directly elevating Neomycin Sulphate prices.
For the Quarter Ending December 2025
Neomycin Sulphate Prices in APAC
- In China, the Neomycin Sulphate Price Index edged up quarter-over-quarter in Q4 2025, driven by rising production costs.
- The Neomycin Sulphate price forecast indicates continued upward pressure from persistent production cost increases during Q4 2025.
- Neomycin Sulphate production costs rose as agricultural and chemical product price indices expanded in December 2025.
- Demand for Neomycin Sulphate faced headwinds as consumer spending exhibited sluggishness throughout Q4 2025.
- Retail sales grew by a modest 0.9% year-over-year in December 2025, indicating weak consumer demand.
- Industrial production advanced by 5.2% year-over-year in December 2025, supporting industrial chemical demand.
- China's manufacturing activity experienced stronger growth in December 2025, as the Manufacturing Index expanded.
- The chemical sector in China faced bottlenecks in Q4 2025, including reliance on imports, impacting supply.
Why did the price of Neomycin Sulphate change in December 2025 in APAC?
- Production costs rose as agricultural and chemical product price indices expanded in December 2025.
- Weak consumer spending, with retail sales growing 0.9% year-over-year in December 2025, tempered demand.
- The Producer Price Index declined by 1.9% year-over-year in December 2025, easing some input cost pressures.
Neomycin Sulphate Prices in North America
- In United States, the Neomycin Sulphate Price Index rose quarter-over-quarter in Q4 2025, driven by increasing production costs and robust demand.
- Neomycin Sulphate production costs increased in Q4 2025, influenced by a 3.0% year-over-year PPI rise in November 2025.
- Feedstock expenses rose due to increased cereal, sugar, and grain prices in December and November 2025.
- Energy costs were impacted by strengthening US natural gas spot prices throughout Q4 2025.
- General inflation, a 2.7% year-over-year CPI increase in December 2025, raised raw material and labor costs.
- Neomycin Sulphate demand outlook remained strong in Q4 2025, supported by a 2.0% year-over-year industrial production increase in December 2025.
- Robust consumer spending, a 3.3% year-over-year retail sales increase in November 2025, boosted Neomycin Sulphate demand.
- A strong labor market (4.4% unemployment in December 2025) and 89.1 consumer confidence supported healthcare spending.
Why did the price of Neomycin Sulphate change in December 2025 in North America?
- Production costs rose due to a 3.0% year-over-year PPI increase in November 2025, impacting prices.
- Demand strengthened, supported by a 2.0% year-over-year industrial production increase in December 2025.
- Energy and feedstock costs, including natural gas prices in Q4 2025, elevated overall expenses.
Neomycin Sulphate Prices in Europe
- In Germany, the Neomycin Sulphate Price Index fell quarter-over-quarter in Q4 2025, driven by a -2.5% decline in producer prices in December 2025.
- Neomycin Sulphate production costs decreased in Q4 2025, influenced by softening global and weakening European sugar prices.
- Consumer demand for Neomycin Sulphate was supported by 1.1% year-on-year retail sales growth in November 2025.
- Industrial demand for Neomycin Sulphate faced headwinds as the Manufacturing Index showed a contracting trend in December 2025.
- The Neomycin Sulphate demand outlook remained stable, supported by 0.8% year-on-year industrial production growth in October 2025.
- Stable consumer purchasing power, with a 6.2% unemployment rate in December 2025, sustained essential Neomycin Sulphate demand.
- Downward pressure on Neomycin Sulphate prices stemmed from a global sugar surplus extending into Q4 2025.
- Elevated electricity costs in Germany throughout Q4 2025 partially offset declining Neomycin Sulphate production expenses.
Why did the price of Neomycin Sulphate change in December 2025 in Europe?
- Producer prices declined by -2.5% in December 2025, reducing Neomycin Sulphate manufacturing costs.
- Global sugar prices softened in December 2025, contributing to lower Neomycin Sulphate feedstock expenses.
- A contracting Manufacturing Index in December 2025 indicated weaker industrial demand for Neomycin Sulphate.
For the Quarter Ending September 2025
Neomycin Sulphate Prices in APAC
- In China, the Neomycin Sulphate Price Index rose by 1.5683% quarter-over-quarter, reflecting modest demand improvement.
- The average Neomycin Sulphate price for the quarter was approximately USD 11333.33/MT as reported locally.
- Neomycin Sulphate Spot Price remained stable amid balanced domestic supply and limited export enquiries recently.
- Neomycin Sulphate Price Forecast points to modest upside risks driven by recovering downstream pharmaceutical demand.
- Neomycin Sulphate Production Cost Trend showed slight increases due to higher raw material and utility expenditures.
- Neomycin Sulphate Demand Outlook improved marginally with seasonal procurement by API manufacturers supporting volumes sustainably.
- Neomycin Sulphate Price Index benefited from constrained shipments and steady operating rates at major Chinese producers.
- Inventory and export demand dynamics supported tighter availability, reinforcing short term regional pricing resilience ahead.
- Why did the price of Neomycin Sulphate change in September 2025 in APAC?
- Domestic pharmaceutical buying uptick increased consumption, tightening local availability and supporting price resilience during quarter.
- Higher feedstock and energy costs nudged production expenses upward, exerting upward pressure on market pricing.
- Logistics delays and constrained export flows reduced supply flexibility, amplifying Price Index sensitivity to demand changes.
Neomycin Sulphate Prices in Europe
- In Germany, the Neomycin Sulphate Price Index rose by 1.56% quarter-over-quarter, reflecting modest demand recovery.
- The average Neomycin Sulphate price for the quarter was approximately USD 11415.00/MT, based on CFR Hamburg reported volumes.
- Neomycin Sulphate Spot Price showed limited upside due to steady inventories and subdued regional export demand.
- Neomycin Sulphate Price Forecast indicates range-bound movement near current levels absent major supply disruptions and significant feedstock-driven inflation.
- Neomycin Sulphate Production Cost Trend remains stable as raw material and energy cost pressures were moderate during the quarter.
- Neomycin Sulphate Demand Outlook points to gradual recovery in institutional tendering and pharmaceutical manufacturing activity.
- Elevated operating rates at regional producers supported the Neomycin Sulphate Price Index despite limited spot transaction volumes.
- Logistics constraints and seasonal procurement patterns mildly supported Neomycin Sulphate transactional premiums in northern European markets.
Why did the price of Neomycin Sulphate change in September 2025 in Europe?
- Improved regional demand recovery increased purchasing activity, tightening availability and supporting modest price appreciation recently.
- Feedstock and energy pricing curbed cost escalation, reducing upward pressure on Neomycin Sulphate Price Index
- Logistics delays and selective tendering increased short-term tightness, marginally elevating transactional premiums across Germany markets.
Neomycin Sulphate Prices in North America
- In USA, the Neomycin Sulphate Price Index rose by 1.62% quarter-over-quarter, driven by export demand.
- The average Neomycin Sulphate price for the quarter was approximately USD 11495.00/MT in North America.
- Neomycin Sulphate Spot Price eased mid-quarter amid softer procurement and cautious short-term buyer behaviour patterns.
- Inventory draws improved late quarter supporting the Neomycin Sulphate Price Index despite narrow producer margins.
- Neomycin Sulphate Production Cost Trend rose slightly as feedstock and energy charges increased regionally overall.
- Neomycin Sulphate Demand Outlook stable with steady pharmaceutical contracts offsetting variable tender volumes at hospitals.
- Neomycin Sulphate Price Forecast suggests modest stability short-term barring unexpected supply disruptions or demand spikes.
- Major producer uptime tempered volatility in the Neomycin Sulphate Price Index and supported export readiness.
Why did the price of Neomycin Sulphate change in September 2025 in North America?
- Export demand firmed late quarter, tightening effective supply and supporting the modest Neomycin Sulphate Price increase.
- Regional feedstock and energy cost pressures lifted production costs, marginally offsetting downward price pressure from inventories.
- Logistics normalization reduced delays but buyer purchasing patterns remained cautious, moderating sharp upside in the Price Index.
